Abstract
Objectives
We investigated the effects of a fermented soy product from lactic acid bacteria (PS-B1) in preventing the decrease in bone mineral content and deterioration of trabecular bone structure in ovariectomized (OVX) mice.
Methods
Four-week-old ICR OVX or sham-operated (Sham) mice were maintained on a normal diet in five groups: a Sham group, the OVX control group, PS-B1 1 % (Ps 1 %) group, PS-B1 2 % (Ps 2 %) group, and PS-B1 5 % (Ps 5 %) group. The Sham and OVX control groups were given tap water as drinking water. Water containing 1, 2, and 5 % PS-B1 was given ad libitum to the respective PS-B1 groups. The animals were kept under these conditions for 12 weeks and sacrificed under anesthesia. Their femurs were removed under sterile conditions. Bone mineral density (BMD) of the removed femurs was measured by use of peripheral quantitative computed tomography. Subsequently, morphometric indices for trabecular bone structure were measured by use of microfocus X-ray computed tomography.
Results
Total BMD, trabecular BMD, and cortical width were significantly higher in the Ps 2 % group than in controls. In the Ps 2 % group, there was a tendency for retarded BMD loss. Maintenance of bone volume fraction, trabecular number, trabecular space, trabecular continuity, and trabecular connectivity were seen in the Ps 2 % and Ps 5 % groups. In the Ps 2 % and Ps 5 % groups, deterioration of trabecular bone structure was significantly inhibited.
Conclusions
These results suggest that PS-B1 is effective in slowing the decrease in BMD and deterioration of trabecular bone structure in OVX mice.
Similar content being viewed by others
References
Tanaka M, Shikama R, Ishibashi G, Honda H, Ogasawara M, Sakakibara R. The value as the nutritional and serum cholesterol effects of the fermented products from milk whey (PS-H1) in rats. J Integr Stud Diet Habits. 2004;14:323–7.
Matsumaru T, Tanaka M, Shikama R, Ishibashi G, Matsuno K, Honda H, et al. Effects of the fermented products from milk whey on defecation in humans. Bull Kyushu Women’s Univ. 2003;40:51–60.
Nodake Y, Ogasawara M, Honda H, Fukasawa M, Sakakibara R. Characterization and preliminary purification of the anti-cancer substance(s) in the fermented products cultivated from soybean milk using lactic acid bacteria. Saito Ho-on Kai Mus Nat Hist Res Bull. 2008;73:17–21.
The National Institutes of Health. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–95.
Kanis JA, Johnell O, DeLaet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237–44.
Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, et al. A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest. 2006;116:1525–34.
Tsuchita H, Goto T, Shimizu T, Yonehara Y, Kuwata T. Dietary casein phosphopeptides prevent bone loss in aged OVX rats. J Nutr. 1996;126:86–93.
Ma DF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2007;62:155–61.
Lind PM, Lind L, Larsson S, Orberg J. Torsional testing and peripheral quantitative computed tomography in rat humerus. Bone. 2001;29:265–70.
Pothuaud L, Lespessailles E, Harba R, Jennane R, Royant V, Eynard E, et al. Fractal analysis of trabecular bone texture on radiographs: discriminant value in postmenopausal osteoporosis. Osteoporos Int. 1998;8:618–25.
Ikuta A, Kumasaka S, Kashima I. Quantitative analysis using the star volume method applied to skeleton patterns extracted with a morphological filter. J Bone Miner Metab. 2000;18:271–7.
Vesterby A, Gunndersen HJG, Melsen F. Star volume of marrow space and trabeculae of the first lumbar vertebra: sampling efficiency and biological variation. Bone. 1989;10:7–13.
Garrahan NJ, Mellich RW, Compston JE. A new method for the two-dimensional analysis of bone structure in human iliac crest biopsies. J Microsc. 1989;142:341–9.
Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–78.
Joint FAO/WHO expert consultation. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Argentina: World Health Organization; 2001.
Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus cassei strain shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998;52:899–907.
Yamano T, Iino H, Takada M, Blum S, Rochat F, Fukushima Y. Improvement of human intestinal flora by ingestion of a probiotic strain of Lactobacillus johnsonii La1. Br J Nutr. 2006;95:303–12.
Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo controlled study. J Dairy Sci. 2005;88:527–33.
Fujiwara D, Wakabayashi H, Watanabe H, Nishida S, Iino H. A double-blind trial of Lactobacillus paracasei strain KW3110 administration for immunomodulation in patients with pollen allergy. Allergol Int. 2005;54:143–9.
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001;357:1076–9.
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allerg. 2000;30:1605–10.
Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in double-blind trial. The BLP Study Group. Eur Urol. 1995;27:104–9.
Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000;64:2706–8.
Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intakes. FEMS Immunol Med Microbiol. 1994;10:55–64.
Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci. 1995;78:491–7.
Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics. 2005;115:5–9.
Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ. 2001;322:15.
Nase L, Hatakka K, Sacilahti E, Saxelin M, Ponka A, Poussa T, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35:412–20.
Kimoto-Nira H, Suzuki C, Kobayashi M, Sasaki K, Kurisaki J, Mizumachi K. Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice. Br J Nutr. 2007;98:1178–86.
Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol. 2007;170:1277–90.
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.
Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;423:349–55.
Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 1998;22:295–9.
Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, et al. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor. J Cell Biochem. 2003;88:1145–56.
Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 1999;13:2179–85.
Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, et al. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006;25:4175–86.
Hinoi E, Fujimori S, Yoneda Y. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblast. FASEB J. 2003;17:1532–4.
Matsubara M, Yamachika E, Tsujigiwa H, Mizukawa N, Ueno T, Murakami J, et al. Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption. Osteoporos Int. 2010;21:1437–47.
Tsugawa N, Shiraki M, Suhara T, Kamao M, Tanaka K, Okano T. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for γ-carboxylation of osteocalcin. Am Clin Nutr. 2006;83:380–6.
Miyake M, Kozai Y, Sakurai T, Kashima I. Effects of citric acid administration on femoral trabecular structures in ovariectomized mice. Oral Radiol. 2007;23:34–41.
Takano T, Kozai Y, Kawamata R, Wakao H, Sakurai T, Kashima I. Inhibitory effect of maritime pine bark extract (Pycnogenol®) on deterioration of bone structure in the distal femoral epiphysis of ovariectomized mice. Oral Radiol. 2011;27:8–16.
Ushiyama S, Yamaguchi M. Inhibitory effects of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol. 2004;67:1297–305.
Conflict of interest
There are no financial or other relationships that could lead to a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miura, T., Kozai, Y., Kawamata, R. et al. Inhibitory effect of a fermented soy product from lactic acid bacteria (PS-B1) on deterioration of bone mass and quality in ovariectomized mice. Oral Radiol 30, 45–52 (2014). https://doi.org/10.1007/s11282-013-0143-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11282-013-0143-3